Sort
10,766 grants matching “checkpoint inhibitor”
Structure and Function of SET Domain Methyltransferases
$252,331Raymond C Trievel · University Of Michigan At Ann Arbor · R01 · FY2008 · GM
Mechanisms of ATR Targeting and Regulation
$252,250Randal Scot Tibbetts · University Of Wisconsin-Madison · R01 · FY2006 · GM
WEE1 inhibition and tumor immunity
$252,247Bin Zhang · Northwestern University At Chicago · R01 · FY2023 · CA
Structure and Function of SET Domain Methyltransferases
$252,230Raymond C Trievel · University Of Michigan At Ann Arbor · R01 · FY2009 · GM
Regulation of Replication Checkpoint by Proteolysis
$252,001Hui Zhang · Nevada Cancer Institute · R01 · FY2008 · CA
Role of Acid in the Development of Barrett's Esophagus
$252,000Rhonda F Souza · Ut Southwestern Medical Center · R01 · FY2007 · DK
REGULATED PROTEOLYSIS AND LONG-TERM MEMORY
$252,000Wake Forest University Health Sciences · R01 · FY2002 · MH
REGULATED PROTEOLYSIS AND LONG-TERM MEMORY
$252,000Wake Forest University Health Sciences · R01 · FY2003 · MH
Evaluating the impact of TP53 mutation on the epigenetic therapy viral mimicry response in the non- small cell lung cancer tumor
$251,961Rachel M. Abbotts · West Virginia University · P20 · FY2025 · GM
New tools for imaging and theranostics in inflammation and cancer
$251,800Sangeeta Ray · Ut Southwestern Medical Center · P41 · FY2024 · EB
Role of polycystin-1 in centrosome duplication and cell cycle control
$251,708Gabriele Luca Gusella · Icahn School Of Medicine At Mount Sinai · R01 · FY2010 · DK
Core 1: Mouse Model and Tissue Biobank Core
$251,669Roger S Lo · Institute For Systems Biology · U54 · FY2025 · CA
Regulation of DNA replication fork progression by ATM kinase activity
$251,490Christopher J. Bakkenist · University Of Pittsburgh At Pittsburgh · R01 · FY2012 · CA
Regulation of DNA replication fork progression by ATM kinase activity
$251,490Christopher J. Bakkenist · University Of Pittsburgh At Pittsburgh · R01 · FY2015 · CA
Regulation of DNA replication fork progression by ATM kinase activity
$251,490Christopher J. Bakkenist · University Of Pittsburgh At Pittsburgh · R01 · FY2011 · CA
PVSRIPO in melanoma
$251,477Georgia Beasley · Duke University · K08 · FY2020 · CA
Multiplexed spatially resolved tissue biomarkers for optimal use of PD-1 axis blockers and PARP inhibitors in cancer.
$251,360Kurt A Schalper · Yale University · UH2 · FY2025 · CA
PVSRIPO in melanoma
$251,345Georgia Beasley · Duke University · K08 · FY2022 · CA
Full Project 1: Understanding and Targeting of Convergent Immunosuppressive Pathways and Molecular Signaling in HPV-positive and HPV-negative Penile Cancer
$251,279Curtis Pettaway · University Of Tx Md Anderson Can Ctr · U54 · FY2021 · CA
Naïve T cell archetypes and anti-tumor immunity
$251,250Carla Rothlin · Yale University · R21 · FY2023 · AI
Development of BBB Permeable PD-L1 PET Imaging Agents
$251,250Zhengxin Cai · Yale University · R21 · FY2019 · EB
Mechanisms of resistance to immune therapy in NSCLC
$251,146Qingsheng Li · University Of Louisville · P20 · FY2023 · GM
CHEK2 loss promotes prostate cancer resistance to PARP inhibitors
$251,048Li Jia · Brigham And Women'S Hospital · R21 · FY2022 · CA
Biochemical Basis for Therapeutic Activity
$251,038University Of Texas Md Anderson Can Ctr · R01 · FY2005 · CA
Biochemical Basis for Therapeutic Activity
$251,038University Of Texas Md Anderson Can Ctr · R01 · FY2004 · CA